Lundbeck CEO Ulf Wiinberg On Partnering For Japan’s CNS Market: An Interview With PharmAsia News (Part 2 of 2)
This article was originally published in PharmAsia News
Executive Summary
Lundbeck is closely tied with Otsuka for CNS development, giving the company the freedom to explore more R&D programs.